I-Mab Announces IND Clearance from FDA for TJM2 to Treat Cytokine Release Syndrome (CRS) Associated with Severe Coronavirus Disease 19 (COVID-19)

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access